Translational potential of preclinical trials of neuroprotection through pharmacotherapy for spinal cord injury.

Journal of neurosurgery. Spine

Volumn 17, Issue 1 Suppl, 2012, Pages 157-229

  Tator, Charles H ^a   Hashimoto, Robin ^b   Raich, Annie ^b   Norvell, Daniel ^b   Fehlings, Michael G ^b   Harrop, James S ^b   Guest, James ^b   Aarabi, Bizhan ^b   Grossman, Robert G ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; MAGNESIUM SULFATE; MINOCYCLINE; NEUROPROTECTIVE AGENT; NIMODIPINE; RILUZOLE;

ANIMAL; DISEASE MODEL; HUMAN; REVIEW; SPINAL CORD INJURY; TRANSLATIONAL RESEARCH;

ANIMALS; DISEASE MODELS, ANIMAL; GLYBURIDE; HUMANS; MAGNESIUM SULFATE; MINOCYCLINE; NEUROPROTECTIVE AGENTS; NIMODIPINE; RILUZOLE; SPINAL CORD INJURIES; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84872185036     PISSN: None     EISSN: 15475646     Source Type: Journal    
DOI: 10.3171/2012.5.aospine12116     Document Type: Review

References (0)